Anya L Greenberg1, Hope Schwartz1, Caitlin R Collins2, Yvonne M Kelly2, Robert Mackersie2,3, Michelle Mourad4, John P Roberts2, Tasce Bongiovanni2,3. 1. School of Medicine, University of California San Francisco, San Francisco, California, USA. 2. Department of Surgery, University of California San Francisco, San Francisco, California, USA. 3. Department of Trauma and Acute Care Surgery, Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco, California, USA. 4. Department of Medicine, University of California San Francisco, San Francisco, California, USA.
As cases of COVID-19 rose in the USA in early 2020, federal, state and local governments enacted interventions to quell the spread of the virus and preserve hospital capacity. Among these interventions was a widespread shift to virtual healthcare and cancellation of elective surgeries. Together with fear of acquiring COVID-19, this interruption in care prompted concerns about patients’ hesitancy to access emergent medical services, as seen previously. Most recently, the 2003 SARS epidemic led to significant reductions in utilization of services across healthcare settings due to fear of acquiring and stigma associated with SARS.1–3Reports early in the pandemic suggested that non-COVID-19 medical and surgical emergencies fell, leading to widespread concern about patient barriers to seeking care and downstream effects on health.4–6 However, current healthcare utilization literature is largely limited to trends immediately following the onset of the COVID-19 pandemic and little is known about changes in volume, demographics and type of presentations for general surgical emergencies (GSEs).Our institution, the University of California, San Francisco (UCSF) Medical Center, cancelled all elective surgical cases on March 13, 20207 and the City and County of San Francisco issued a shelter-in-place (SIP) order on March 16, 2020,8 specifying that adults aged 65+ years should isolate at home.9 In addition, San Francisco public transportation was significantly scaled back, onsite community clinics closed and lack of patient access to technology and provider training limited telehealth expansion. These barriers to accessing care may disproportionately impact vulnerable populations already at higher risk of COVID-19.10 These include patients who are older, have comorbidities, are from structurally disadvantaged racial and ethnic groups, have limited English proficiency and are uninsured/underinsured.11 12In this study, we aimed to assess changes in GSE volume, patient demographics and illness severity of presentation during COVID-19 and to determine if particular groups were disproportionately affected.
Methods
All adults (aged ≥18 years) presenting to the emergency department (ED), regardless of ED disposition, for potential GSEs at a single tertiary-care hospital between January 2018 and August 2020 were included. Data were extracted from the UCSF electronic medical record (EMR) system. Defined by International Classification of Diseases-10 (ICD-10) code, we included gastric ulcer, duodenal ulcer, peptic ulcer, appendicitis, diverticular disease, other diseases of the intestine, peritonitis, cholelithiasis, cholecystitis and acute pancreatitis (Online supplemental file 1). Demographic variables included age, sex, race/ethnicity, interpreter use and payor, all variables included in our EMR. Proxy measures for disease severity included severity of illness (SOI) score,13 sepsis (based on ICD-10 code) and length of stay (LOS). The SOI index, whereby a severity score is assigned to each patient at discharge based on seven clinically relevant dimensions (including diagnosis, complications, concurrent conditions, among others), is the standard severity index tracked by our Medical Center. Other metrics measuring severity included white blood cell (WBC) count at presentation and maximum WBC in the first 24 hours of hospitalization.To compare GSE case volumes, an interrupted time-series (ITS) analysis was performed using segmented linear regression comparing the two time periods designated pre-COVID-19 (January 1, 2018–March 15, 2020) and during COVID-19 (March 16, 2020–August 31, 2020), using San Francisco’s March 16, 2020 SIP order as the start of the COVID-19 period. The Durbin-Watson statistic was used to test for autocorrelation of error terms in the regression model, with values <1 or >3 indicating concern. Each hospitalization encounter was treated independently in the analysis because the percentage of patients with more than one hospital encounter during the study period was below a previously accepted cut-off.14 We also completed ITS analyses on seven subgroups by disease process: ulcer, appendicitis, gallbladder disease, peritonitis, acute pancreatitis, diverticular disease and other diseases of the intestine. We used an ITS to examine changes in the percentage of patients whose GSEs were surgically managed in the two time periods. Bivariate analyses were used to compare patient demographic and disease severity characteristics before and during COVID-19, including t-tests for continuous variables and χ2 tests for categorical variables.Data analysis was completed in SAS V.9.4 (SAS Institute, Cary, North Carolina, USA) and Stata V.16 (StataCorp, College Station, Texas, USA). P values of ≤0.05 were considered to be statistically significant.
Results
Pre-COVID-19, a total of 3255 patients (28/week) presented with potential GSEs (71% admitted), compared with during COVID-19, when 546 (23/week) presented (77% admitted). When SIP started, presentations fell by 8.7/week (31%) from the previous week (95% CI (−13.9 to –3.57), p<0.001) and subsequently increased towards pre-COVID-19 levels the following weeks.However, the overall change in number of GSE presentations per week during COVID-19 was not significantly different from the change in number of GSE presentations per week pre-COVID-19 (difference in slopes=0.28, 95% CI (−0.07 to 0.62), p=0.12). Both time periods had non-significant positive slopes for change in the number of GSE presentations per week. Pre-COVID-19, the number GSE presentations increased by 0.0009 per week (95% CI (−0.03 to 0.03), p=0.96), and during COVID-19 the number of GSE presentations increased by about 0.28 per week (95% CI (−0.07 to 0.62), p=0.12) (figure 1). Correction for autocorrelation was not done as the Durbin-Watson test statistics did not indicate concern.
Figure 1
General surgery emergency presentation volumes before and during the COVID-19 pandemic. ED, emergency department.
General surgery emergency presentation volumes before and during the COVID-19 pandemic. ED, emergency department.The same analysis was performed on the seven subgroups of interest, with only the peritonitis and gallbladder disease subgroups having significant differences in number of presentations between the pre-COVID-19 and during COVID-19 time periods (online supplemental file 1). During the first week after the SIP order, the number of ED presentations in each of these two subgroups decreased by nearly three from the previous week (peritonitis: β=−2.76, 95% CI (−5.03 to –0.48), p=0.017; gallbladder disease: β=−2.91, 95% CI (−5.28 to –0.54), p=0.016). However, the change in the number of ED presentations per week (slope) during COVID-19 was not significantly different from the change in number of ED presentations per week pre-COVID-19 for either subgroup (figure 2A, B).
Figure 2
Peritonitis (A) and gallbladder disease (B) emergency department (ED) presentation volumes before and during the COVID-19 pandemic.
Peritonitis (A) and gallbladder disease (B) emergency department (ED) presentation volumes before and during the COVID-19 pandemic.By demographic characteristics, the mean age pre-COVID-19 was 56.86 years, compared with 53.95 years during COVID-19 (p=0.001) (table 1). This was driven by a decrease in the proportion of patients aged 50–64 years (23% vs 28% pre-COVID-19) and 65+ years (34% vs 37% pre-COVID-19) and an increase in the proportion of patients aged 18–34 years (21% vs 15% pre-COVID-19). During COVID-19, patients were less likely to have public insurance (Medicare or Medicaid) and more likely to have private insurance (p=0.024). Among patients below the Medicare age cut-off of 65 years, the proportion who were publicly insured fell from 45% to 37% (p=0.005). During COVID-19, fewer patients required the use of an interpreter (12% vs 15% pre-COVID-19, p<0.001). There were no differences in GSE presentations by gender (p=0.058) or race/ethnicity (p=0.181) pre-COVID-19 and during COVID-19.
Table 1
Demographic characteristics pre-COVID-19 and during COVID-19
Pre-COVID-19 (n=3255)
Post-COVID-19 (n=546)
P value
Mean/N
%
Mean/N
%
Age
56.86
53.95
0.001
Age group (years)
0.001
18–34
473
15
114
21
35–49
664
20
117
21
50–64
900
28
127
23
65+
1218
37
188
34
Gender
0.058
Female
1603
49
293
54
Male
1650
51
253
46
Race/Ethnicity
0.181
White or Caucasian
1526
47
269
49
Asian
649
20
105
19
Hispanic or Latino
532
16
75
14
Black or African-American
263
8
46
8
American Indian, Alaska Native, Native Hawaiian or other Pacific Islander
79
2
7
1
Other/Unknown
206
6
44
8
Interpreter needed
<0.001
Yes
485
15
67
12
No
2735
85
470
87
Unknown
2
0
5
1
Coverage type
0.024
Medicare
1331
41
196
36
Private coverage
1210
38
238
44
Medi-Cal
669
21
102
19
Other
45
1
10
2
Demographic characteristics pre-COVID-19 and during COVID-19The percentage of people who had surgery for their GSEs was 46% during COVID-19, compared with 52% pre-COVID-19 (p=0.007) (table 2), largely driven by a drop to 20% and 24% in the first and second week after SIP, respectively (β=−9.87, 95% CI (−18.6 to –1.15), p=0.027) (figure 3). In terms of illness severity, the lowest SOI group (minor) increased from 14% of the population pre-COVID-19 to 19% during COVID-19, and the highest SOI group (extreme) decreased from 30% to 20% (p<0.001). Fewer patients presented with sepsis during COVID-19 (15% vs 20% pre-COVID-19, p=0.009). After excluding high outliers with LOS >30 days, average LOS was 3.91 days during COVID-19 compared with 5.50 pre-COVID-19 (p<0.001). While during COVID-19 there was a decrease in WBC at presentation (10.8 vs 11.24 pre-COVID-19) and maximum WBC in the first 24 hours after presentation (11.37 vs 11.83 pre-COVID-19), differences were not statistically significant (p=0.225 and p=0.230, respectively).
Table 2
Disease severity metrics pre-COVID-19 and during COVID-19
Pre-COVID-19 (n=3255)
Post-COVID-19 (n=546)
P value
Mean/N
%
Mean/N
%
Surgery
0.007
No
1569
49
297
54
Yes
1686
52
249
46
SOI
<0.001
Minor
349
14
73
19
Moderate
642
25
126
32
Major
820
32
116
30
Extreme
769
30
77
20
LOS
5.50
3.91
<0.001
WBC at presentation
11.24
10.80
0.225
Maximum WBC in the first 24 hours
11.83
11.37
0.230
Sepsis
650
20
83
15
0.009
LOS, length of stay; SOI, severity of illness; WBC, white blood cell.
Figure 3
Percentage of patients with surgical intervention for general surgery emergency before and during the COVID-19 pandemic. ED, emergency department.
Percentage of patients with surgical intervention for general surgery emergency before and during the COVID-19 pandemic. ED, emergency department.Disease severity metrics pre-COVID-19 and during COVID-19LOS, length of stay; SOI, severity of illness; WBC, white blood cell.
Discussion
In this study, we investigated the change in volume and characteristics of GSEs during the COVID-19 pandemic. Our results show that the number of GSEs dropped drastically in the period immediately after the SIP order in San Francisco, but over time rebounded to rates closer to those pre-COVID-19. The largest drivers of this drop were generalized peritonitis and gallbladder disease. One possible explanation of the drop in volume is decreased number of ED presentations for postoperative complications due to the cancellation of elective surgeries. However, the timing of the drop preceded our institutions’ cancellation of elective surgery, thus is unlikely to be the primary factor. However, the drop in volume we saw at our institution is consistent with other studies, which found that patients stayed home rather than presenting to the hospital for multiple different medical and surgical conditions during COVID-19.5 6 15–19 Importantly, patients presenting after the SIP order were less likely to be elderly, publicly insured and have limited English proficiency, revealing a possible disparity in access to care in these groups.We found that the rate of patients presenting with sepsis as well as the overall SOI score decreased during COVID-19. The progression of untreated GSEs typically includes fever, anorexia and pain, which generally prompts patients to present to an ED. We had hypothesized that during COVID-19 patients would delay presenting to the ED due to exposure concern, and would thus present at a later, more severe stage of disease. However, contrary to our expectations, we found that average severity of patients presenting with GSEs actually decreased. These findings prompt concern that the most critically ill patients may be dying at home of surgical disease during COVID-19. This may be related to SIP messaging targeted at older adults, who already have lower reserve and may be less resilient to delays in care. This possibility has been raised in other disease processes, such as heart failure or myocardial infarction, and is supported by the declining volumes and reduced average severity of patients who present to the ED.We were similarly surprised that average LOS decreased during COVID-19. We speculate three drivers. First, shorter LOS is consistent with our finding of decreased illness severity. Second, our organization’s shift towards non-operative antibiotic management early in the pandemic, when the risks of laparoscopic surgery were not fully understood, may have contributed to shorter hospitalizations. Finally, cancellation of elective cases at our institution may have allowed for more timely operative intervention for those who warranted it, resulting in an overall LOS.Understanding which populations are facing increased barriers to care and targeting public health messaging for these groups is especially critical as COVID-19 persists. The fact that the proportion of younger, English-speaking and privately insured patients at presentation is significantly higher during COVID-19 raises concern that older, non-English speaking and publicly insured adults are disproportionately affected. While the transition to telemedicine has increased access to care for many patients, challenges in the rapid scaling of telehealth services may have inequitably impacted already vulnerable populations, including those with less access to technology or technological literacy.20 This is critical knowledge in order to target public service announcements to older adults and ensure that information is distributed in non-English languages. Notably, we saw a decreased proportion of patients needing an interpreter during COVID-19, while no difference in race/ethnicity was observed. This is likely driven by the sizeable number of patients from the Middle East and Eastern Europe that our medical center serves. These patients may not be proficient in English but would be classified as ‘white or Caucasian’, underscoring the importance to consider a broad spectrum of languages.Additionally, older patients may require increased outreach and support in the use of telehealth platforms so they can seek advice on whether to present to a hospital. Increased focus on restoring access to care in these groups is important across healthcare settings, not only in GSEs, as the COVID-19 pandemic persists and SIP orders continue. Our findings suggest that these groups should be specifically targeted in public health messaging related to stay-at-home orders and outreach efforts around vaccination. Furthermore, while COVID-19 has highlighted these disparities in the context of a public health crisis, these groups may continue to be vulnerable to future social and economic events.A limitation of this study is that it is a single-center investigation, thus limiting our ability to understand ED presentations to outside hospitals. However, UCSF Medical Center is the largest and busiest hospital in San Francisco and third in California, thus reaching a large proportion of patients from our region. Second, the San Francisco SIP order was announced early and the city was less impacted by COVID-19 relative to other geographies, which may limit the generalizability of our findings. However, at the onset of SIP, the trajectory that COVID-19 would take in our region was unknown; thus, fear of the disease, and insufficient messaging and access to telehealth to overcome it, rather than the severity of the COVID-19 outbreak itself, may still drive significant changes in patient behavior. Future research should aim to examine region-wide trends in ED presentations (eg, using a statewide database) to confirm differences in presentation for underserved communities; investigate whether the onset of COVID-19 impacted causes of death outside the hospital to understand if patients with serious GSEs died at home; and develop infrastructure to increase hospital and telemedicine access for vulnerable populations, especially older adults, as the pandemic continues.
Conclusion
The number of patients presenting with GSEs fell at the onset of COVID-19. This significant drop, together with the fact that average severity at presentation decreased, raises the possibility that critically ill individuals died at home rather than presenting to a hospital. The disproportionate drop in older, publicly insured and non-English-speaking patients suggests that COVID-19 is potentially exacerbating underlying health disparities. Further work should be done to develop outreach strategies for vulnerable communities, increase telehealth access and investigate potential deaths at home.
Authors: Matthew D Solomon; Edward J McNulty; Jamal S Rana; Thomas K Leong; Catherine Lee; Sue-Hee Sung; Andrew P Ambrosy; Stephen Sidney; Alan S Go Journal: N Engl J Med Date: 2020-05-19 Impact factor: 91.245
Authors: Elizabeth M Lancaster; Julie A Sosa; Amanda Sammann; Logan Pierce; Wen Shen; Michael C Conte; Elizabeth C Wick Journal: J Am Coll Surg Date: 2020-04-09 Impact factor: 6.113
Authors: Santiago Garcia; Mazen S Albaghdadi; Perwaiz M Meraj; Christian Schmidt; Ross Garberich; Farouc A Jaffer; Simon Dixon; Jeffrey J Rade; Mark Tannenbaum; Jenny Chambers; Paul P Huang; Timothy D Henry Journal: J Am Coll Cardiol Date: 2020-04-10 Impact factor: 24.094
Authors: Anthony D Lucero; Andre Lee; Jenny Hyun; Carol Lee; Chadi Kahwaji; Gregg Miller; Michael Neeki; Joshua Tamayo-Sarver; Luhong Pan Journal: West J Emerg Med Date: 2020-09-24
Authors: Paul Park; Ruth Laverde; Greg Klazura; Ava Yap; Bruce Bvulani; Bertille Ki; Toussaint W Tapsoba; Emmanuel A Ameh; Maryrose Osazuwa; Michele Ugazzi; José Daza; Emma Bryce; David Cunningham; Doruk Ozgediz Journal: World J Surg Date: 2022-03-10 Impact factor: 3.352
Authors: Steven L Cochrun; Timothy Finnegan; Grace E Kennedy; Mason Garland; Jayleen M Grams; Abhishek D Parmar Journal: Am J Surg Date: 2022-09-27 Impact factor: 3.125